Evidence map›Paper›PMID 41847700›Full record

ArticleFrontiers in oncology2026

Correction: Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib.

Brian Abboud, Nehemias Guevara Rodriguez, Arslan Babar, Noemy Coreas, Katherine Robbins, Ranju Kunwor

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Brian AbboudDepartment of Internal Medicine, SSM Health-Saint Louis University School of Medicine, Saint Louis, MO, United States.
Nehemias Guevara RodriguezDivision of Hematology, Oncology and Bone Marrow Transplant, Department of Internal Medicine, SSM-Health Saint Louis University School of Medicine, St. Louis, MO, United States.
Arslan BabarDivision of Hematology, Oncology and Bone Marrow Transplant, Department of Internal Medicine, SSM-Health Saint Louis University School of Medicine, St. Louis, MO, United States.
Noemy CoreasDepartment of Gynecologic Oncology, Salvadoran Social Security Institute (ISSS), University of El Salvador (UES), San Salvador, El Salvador.
Katherine RobbinsDepartment of Pathology, SSM-Health Saint Louis University School of Medicine, Saint Louis, MO, United States.
Ranju KunworDivision of Hematology, Oncology and Bone Marrow Transplant, Department of Internal Medicine, SSM-Health Saint Louis University School of Medicine, St. Louis, MO, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2026.1765255.].

Indexed as

bruton tyrosine kinase (BTK) inhibitorCLL (chronic lymphocytic leukemia)hematologyimmunosuppressionmalignant hematologic diseaserenal transplantzanubrutinibzanubrutinib acute kidney injury as initial manifestation of chronic lymphocytic leukemia/small lymphocytic lymphoma

Identifiers

PMID41847700
PMCPMC12990181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.